Fund shareholders of Neurocrine Biosciences Inc
ISIN US64125C1099 · United States · LEI 549300FECER0XBN49756
- Fund shareholders
- 648
- Of which ETFs
- 170 478 other funds
- Value held
- 5.1B $ 1.4B SEK · 12M €
- Share of capital
- 39.5 % of 101.6M shares on Jul 22, 2026
648 funds hold this company. This table lists the 636 that declare it in a regulatory filing. The other 12 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| JPMorgan U.S. Research Enhanced Large Cap ETF J.P. Morgan Exchange-Traded Fund Trust | 162 | 21.3K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Pacer S&P MidCap 400 Quality FCF Aristocrats ETF Pacer Funds Trust | 162 | 21.3K $ | 2.17 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Xtrackers Russell 1000 US Quality at a Reasonable Price ETF DBX ETF Trust | 156 | 20.6K $ | 0.03 % | 0.00 % | as of Feb 27, 2026 ↗ |
| SIMT Mid-Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 150 | 19.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| The ESG Growth Portfolio HC Capital Trust | 130 | 17.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco QQQ Hedged Advantage ETF Invesco Actively Managed Exchange-Traded Fund Trust | 128 | 16.9K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| RiverNorth Patriot ETF Elevation Series Trust | 121 | 15.9K $ | 0.42 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Value ETF Columbia ETF Trust I | 108 | 14.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 102 | 13.5K $ | 0.22 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 98 | 12.9K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| The Catholic SRI Growth Portfolio HC Capital Trust | 97 | 12.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Mid Cap Value Portfolio SEASONS SERIES TRUST | 87 | 11.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Mid-Cap 1.5x Strategy Fund Rydex Variable Trust | 84 | 11.1K $ | 0.33 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Managed Volatility V.I. Fund BlackRock Variable Series Funds, Inc. | 83 | 10.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 80 | 10.6K $ | 0.12 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Sector Rotation Fund Meeder Funds | 78 | 10.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF Morgan Stanley ETF Trust | 74 | 9.7K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity Covington Trust | 73 | 9.6K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Overlay B Portfolio BERNSTEIN SANFORD C FUND INC | 71 | 9.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 63 | 8.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Tax-Aware Overlay B Portfolio BERNSTEIN SANFORD C FUND INC | 56 | 7.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 55 | 7.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SEB Global Exposure SEB Funds AB | 44 | 55.2K SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Strategist Portfolio MORGAN STANLEY VARIABLE INSURANCE FUND INC. | 43 | 5.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Lazard Retirement Global Dynamic Multi-Asset Portfolio LAZARD RETIREMENT SERIES INC | 39 | 5.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Hedged Equity Portfolio Variable Insurance Products Fund VI | 30 | 4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 23 | 3K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Active Core U.S. Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 23 | 3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morningstar Alternatives Fund Morningstar Funds Trust | 23 | 3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Enhanced Large Cap Core Active ETF BlackRock ETF Trust | 17 | 2.2K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) MSCI USA Climate Paris Aligned ETF SPDR SERIES TRUST | 7 | 922.2 $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BBVA MEGATENDENCIA TECNOLOGÍA, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 10.6M € | 0.65 % | as of Dec 31, 2025 ↗ | ||
| ABANCA RENTA VARIABLE CRECIMIENTO, FI ABANCA GESTION DE ACTIVOS, SGIIC, SA | 743.3K € | 0.76 % | as of Dec 31, 2025 ↗ | ||
| MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. | 461.6K € | 2.59 % | as of Dec 31, 2025 ↗ | ||
| COMPROMISO MEDIOLANUM, FI MEDIOLANUM GESTION, S.G.I.I.C., S.A. | 114.5K € | 0.28 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 72.3K € | 1.97 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.66 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 3.68 % | as of Apr 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.45 % | as of Mar 31, 2026 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 3.30 % | as of Dec 31, 2025 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 3.22 % | as of Mar 31, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 3.16 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.15 % | as of Sep 30, 2025 ↗ |
| Baird Small/Mid Cap Growth Fund Baird Funds Inc | 2.94 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 2.86 % | as of Apr 30, 2026 ↗ |
| MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. | 2.59 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 600 | -3 | 39,005,444 | -0.7 % |
| 2026Q1 | 603 | -9 | 39,263,230 | -4.2 % |
| 2025Q4 | 612 | +11 | 40,996,168 | -4.4 % |
| 2025Q3 | 601 | -6 | 42,897,103 | +2.8 % |
| 2025Q2 | 607 | -27 | 41,721,880 | +7.3 % |
| 2025Q1 | 634 | -24 | 38,886,077 | +4.9 % |
| 2024Q4 | 658 | -8 | 37,086,789 | -2.5 % |
| 2024Q3 | 666 | +50 | 38,056,358 | +5.0 % |
| 2024Q2 | 616 | +15 | 36,239,577 | +1.1 % |
| 2024Q1 | 601 | +31 | 35,855,892 | +2.7 % |
| 2023Q4 | 570 | 34,930,179 |
Institutional managers
682 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 13,385,607 | 1.8B $ | as of Mar 31, 2026 |
| Dodge & Cox | 5,461,037 | 719.4M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 5,442,067 | 700.5M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 4,938,967 | 650.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,354,526 | 573.7M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,060,570 | 403.2M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,418,897 | 318.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,136,672 | 280.8M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,493,813 | 196.8M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,389,539 | 183.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,250,000 | 164.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,247,447 | 164.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,242,830 | 163.7M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,221,036 | 160.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,219,196 | 160.6M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,062,072 | 139.9M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 959,217 | 126.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 902,788 | 118.9M $ | as of Mar 31, 2026 |
| IEQ CAPITAL, LLC | 765,982 | 100.9M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 731,609 | 96.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 724,000 | 95.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 711,762 | 93.8M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 702,492 | 92.5M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 652,121 | 85.9M $ | as of Mar 31, 2026 |
| Fiera Capital Corp | 651,255 | 85.8M $ | as of Mar 31, 2026 |
Declared shareholders of Neurocrine Biosciences Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.23 % | 5,257,941 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Neurocrine Biosciences Inc". https://titelia.com/en/stocks/neurocrine-biosciences-inc-US64125C1099